Baker Tilly Wealth Management, LLC Glaukos Corp Transaction History

Baker Tilly Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$69.23 - $79.09 $82,937 - $94,749	-1,198 Reduced 20.19%	4,736 $356,000
Q1 2023 Apr 12, 2023	BUY	$43.88 - $52.48 $7,064 - $8,449	161 Added 2.79%	5,934 $297,000
Q4 2022 Jan 26, 2023	BUY	$40.82 - $57.75 $163 - $231	4 Added 0.07%	5,773 $0
Q3 2022 Oct 20, 2022	BUY	$46.84 - $58.49 $17,049 - $21,290	364 Added 6.73%	5,769 $307,000
Q2 2022 Jul 28, 2022	SELL	$34.86 - $63.77 $488 - $892	-14 Reduced 0.26%	5,405 $245,000
Q1 2022 Apr 27, 2022	BUY	$44.33 - $57.82 $240,224 - $313,326	5,419 New	5,419 $313,000
Q3 2021 Nov 02, 2021	SELL	$47.43 - $84.23 $162,305 - $288,235	-3,422 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$73.06 - $97.7 $438 - $586	6 Added 0.18%	3,422 $290,000
Q4 2020 Feb 03, 2021	BUY	$48.9 - $75.26 $167,042 - $257,088	3,416 New	3,416 $257,000

342

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Baker Tilly Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Baker Tilly Wealth Management, LLC with notifications on news.